Stanford researchers find that oral anti-fungal drug can treat skin cancer in patients
- Posted: February 4, 2014
A new study shows that a common anti-fungal treatment called itraconazole may be useful in treating basal cell carcinoma -- the most common form of skin cancer.
Click here to read the full press release.
Among the research institutions NCI funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.